IDEXX LABORATORIES INC (IDXX) Stock Price & Overview

NASDAQ:IDXX • US45168D1046

Current stock price

573.54 USD
-7.22 (-1.24%)
Last:

The current stock price of IDXX is 573.54 USD. Today IDXX is down by -1.24%. In the past month the price decreased by -1.06%. In the past year, price increased by 41.14%.

IDXX Key Statistics

52-Week Range402.85 - 769.98
Current IDXX stock price positioned within its 52-week range.
1-Month Range548.51 - 605.82
Current IDXX stock price positioned within its 1-month range.
Market Cap
45.551B
P/E
43.88
Fwd P/E
38.73
EPS (TTM)
13.07
Dividend Yield
N/A

IDXX Stock Performance

Today
-1.24%
1 Week
-1.87%
1 Month
-1.06%
3 Months
-18.82%
Longer-term
6 Months -8.60%
1 Year +41.14%
2 Years +17.86%
3 Years +18.00%
5 Years +5.79%
10 Years +588.51%

IDXX Stock Chart

IDEXX LABORATORIES INC / IDXX Daily stock chart

IDXX Stock Screens

IDXX currently appears in the following ChartMill screener lists.

IDXX Technical Analysis

ChartMill assigns a technical rating of 1 / 10 to IDXX. When comparing the yearly performance of all stocks, IDXX turns out to be only a medium performer in the overall market: it outperformed 57.22% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

IDXX Fundamental Analysis

ChartMill assigns a fundamental rating of 7 / 10 to IDXX. IDXX scores excellent points on both the profitability and health parts. This is a solid base for a good stock.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

IDXX Earnings

On February 2, 2026 IDXX reported an EPS of 3.08 and a revenue of 1.09B. The company beat EPS expectations (3.12% surprise) and missed revenue expectations (-0.31% surprise).

Next Earnings DateMay 5, 2026
Last Earnings DateFeb 2, 2026
PeriodQ4 / 2025
EPS Reported$3.08
Revenue Reported1.091B
EPS Surprise 3.12%
Revenue Surprise -0.31%

IDXX Forecast & Estimates

22 analysts have analysed IDXX and the average price target is 761.3 USD. This implies a price increase of 32.74% is expected in the next year compared to the current price of 573.54.

For the next year, analysts expect an EPS growth of 13.3% and a revenue growth 9.17% for IDXX


Analysts
Analysts80.91
Price Target761.3 (32.74%)
EPS Next Y13.3%
Revenue Next Year9.17%

IDXX Groups

Sector & Classification

IDXX Financial Highlights

Over the last trailing twelve months IDXX reported a non-GAAP Earnings per Share(EPS) of 13.07. The EPS increased by 16.18% compared to the year before.


Income Statements
Revenue(TTM)4.30B
Net Income(TTM)1.06B
Industry RankSector Rank
PM (TTM) 24.62%
ROA 31.62%
ROE 65.99%
Debt/Equity 0.48
Chartmill High Growth Momentum
EPS Q2Q%17.56%
Sales Q2Q%14.28%
EPS 1Y (TTM)16.18%
Revenue 1Y (TTM)10.42%

IDXX Ownership

Ownership
Inst Owners95.6%
Shares79.42M
Float78.85M
Ins Owners0.21%
Short Float %2.42%
Short Ratio3.53

IDXX Latest News, Press Relases and Analysis

About IDXX

Company Profile

IDXX logo image IDEXX Laboratories, Inc. engages in the development, manufacture, and distribution of products and services for the animal veterinary, livestock and poultry, dairy, and water testing markets. The company is headquartered in Westbrook, Maine and currently employs 11,000 full-time employees. The firm also provides human medical point-of-care and laboratory diagnostics. Its segments include Companion Animal Group (CAG), Water quality products (Water), and Livestock, Poultry and Dairy (LPD). The CAG segment offers diagnostic and information management-based products and services for the companion animal veterinary industry, including in-clinic diagnostic solutions, outside reference laboratory services, and veterinary software and services. The Water segment provides testing solutions for accurate detection and quantification of various microbiological parameters in water. The LPD segment provides diagnostic tests, services, and related instrumentation that are used to manage the health status of livestock and poultry, and to improve the quality and safety of milk.

Company Info

IPO: 1991-06-21

IDEXX LABORATORIES INC

One Idexx Drive

Westbrook MAINE 04092 US

CEO: Jonathan J. Mazelsky

Employees: 11000

IDXX Company Website

IDXX Investor Relations

Phone: 12075560300

IDEXX LABORATORIES INC / IDXX FAQ

What does IDEXX LABORATORIES INC do?

IDEXX Laboratories, Inc. engages in the development, manufacture, and distribution of products and services for the animal veterinary, livestock and poultry, dairy, and water testing markets. The company is headquartered in Westbrook, Maine and currently employs 11,000 full-time employees. The firm also provides human medical point-of-care and laboratory diagnostics. Its segments include Companion Animal Group (CAG), Water quality products (Water), and Livestock, Poultry and Dairy (LPD). The CAG segment offers diagnostic and information management-based products and services for the companion animal veterinary industry, including in-clinic diagnostic solutions, outside reference laboratory services, and veterinary software and services. The Water segment provides testing solutions for accurate detection and quantification of various microbiological parameters in water. The LPD segment provides diagnostic tests, services, and related instrumentation that are used to manage the health status of livestock and poultry, and to improve the quality and safety of milk.


What is the current price of IDXX stock?

The current stock price of IDXX is 573.54 USD. The price decreased by -1.24% in the last trading session.


Does IDXX stock pay dividends?

IDXX does not pay a dividend.


What is the ChartMill rating of IDEXX LABORATORIES INC stock?

IDXX has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 7 out of 10.


What is the analyst forecast for IDXX stock?

22 analysts have analysed IDXX and the average price target is 761.3 USD. This implies a price increase of 32.74% is expected in the next year compared to the current price of 573.54.


What is IDEXX LABORATORIES INC worth?

IDEXX LABORATORIES INC (IDXX) has a market capitalization of 45.55B USD. This makes IDXX a Large Cap stock.